Christopher Cole is Associate Editorial Director for BioPharm International®, Pharmaceutical Technology®, and Pharmaceutical Technology Europe™.
Early Data Show Potential of Tevard’s tRNA Therapy in Duchenne Muscular Dystrophy
Tevard's tRNA therapy appears to restore full-length dystrophin and motor function in a Duchenne muscular dystrophy model, showing promise for nonsense mutation treatments.